Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Milind S. Deshpande
Age : 65
Public asset : 79,966 USD
Linked companies : Spero Therapeutics, Inc.
Summary 
Milind Deshpande is a Venture Partner at RA Capital, and President & CEO of Nayan Therapeutics, a RA Capital portfolio company. Milind has more than 25 years of leadership and operational experience through all stages of drug discovery and development.

He is the co-founder and Chairman of the Board of Directors of Spero Therapeutics, and past President, CEO and member of the Board of Directors of Achillion Pharmaceuticals. Prior to joining Achillion, Milind was Group Leader at Bristol-Myers Squibb for all early stage discovery programs in infectious diseases and neuroscience.

He is the co-inventor of first-in-class HCV NS5A inhibitors, which led to the approval of DaklinzaTM, the first marketed drug in its class. Milind has co-authored more than 80 scientific articles, is co-inventor on 30 patents, and is a frequent speaker at international scientific conferences.

He received his doctorate in Organic Chemistry from Ohio University, and was a Fellow and Instructor in Department of Medicine, Boston University School of Medicine. Milind attended the residential Executive Program at The Wharton School of Management.


Current positions of Milind S. Deshpande 
NameTitle Since
Spero Therapeutics, Inc.
(Biotechnology & Medical Research)
Chairman -
Clear Creek Bio, Inc. Board Member 2020
Nayan Therapeutics, Inc. President, Chief Executive Officer & Director 2019
Santi Therapeutics, Inc. Chief Executive Officer & Board Member 2019
Avilar Therapeutics, Inc. Chairman 2021
RA Capital Management LP (Private Equity) Venture Partner 2018


Holdings of Milind S. Deshpande 
NameEquities%Valuation
Spero Therapeutics, Inc. (SPRO)
(Biotechnology & Medical Research)
16,4540.050%79,966 USD


Milind S. Deshpande: Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/09ELON MUSK : Musk tweet on Japan doomed by low birthrate provokes anger - but not just at him
RE
More news


© 2022 People and Ownership :   
Milind S. Deshpande : Connections